IMA Wealth Inc. Lowers Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

IMA Wealth Inc. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 8.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 7,280 shares of the healthcare conglomerate’s stock after selling 707 shares during the quarter. IMA Wealth Inc.’s holdings in UnitedHealth Group were worth $3,656,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Assetmark Inc. grew its position in UnitedHealth Group by 5.2% during the third quarter. Assetmark Inc. now owns 213,353 shares of the healthcare conglomerate’s stock valued at $83,366,000 after acquiring an additional 10,463 shares during the period. Lincoln National Corp grew its position in UnitedHealth Group by 15.1% during the fourth quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock valued at $4,495,000 after acquiring an additional 1,174 shares during the period. Dohj LLC grew its position in UnitedHealth Group by 4.2% during the third quarter. Dohj LLC now owns 6,446 shares of the healthcare conglomerate’s stock valued at $2,968,000 after acquiring an additional 257 shares during the period. YorkBridge Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 1.8% during the fourth quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock worth $7,681,000 after purchasing an additional 272 shares in the last quarter. Finally, Alexandria Capital LLC lifted its stake in shares of UnitedHealth Group by 3.5% during the third quarter. Alexandria Capital LLC now owns 17,100 shares of the healthcare conglomerate’s stock worth $6,682,000 after purchasing an additional 584 shares in the last quarter. 87.48% of the stock is owned by hedge funds and other institutional investors.

UNH traded up $5.75 during trading on Thursday, reaching $503.84. The stock had a trading volume of 90,605 shares, compared to its average volume of 3,325,221. UnitedHealth Group Incorporated has a 1-year low of $383.12 and a 1-year high of $553.29. The stock has a 50 day moving average of $510.72 and a two-hundred day moving average of $486.27. The firm has a market capitalization of $472.69 billion, a price-to-earnings ratio of 27.26, a price-to-earnings-growth ratio of 1.49 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, topping analysts’ consensus estimates of $5.40 by $0.09. The business had revenue of $80.15 billion for the quarter, compared to the consensus estimate of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. UnitedHealth Group’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period in the prior year, the business posted $5.31 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.

In other news, Director Richard T. Burke sold 3,000 shares of the firm’s stock in a transaction dated Thursday, March 24th. The stock was sold at an average price of $508.80, for a total value of $1,526,400.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 4,000 shares of the stock in a transaction dated Tuesday, March 22nd. The shares were sold at an average price of $511.14, for a total transaction of $2,044,560.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,000 shares of company stock worth $8,823,765. 0.55% of the stock is currently owned by company insiders.

A number of research analysts have commented on the company. BMO Capital Markets boosted their price objective on UnitedHealth Group from $510.00 to $600.00 and gave the stock a “market perform” rating in a research note on Tuesday, April 19th. Morgan Stanley boosted their price objective on UnitedHealth Group from $570.00 to $577.00 and gave the stock an “overweight” rating in a research note on Monday, April 18th. Cowen boosted their price target on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Cowen boosted their price target on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Finally, SVB Leerink boosted their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 19th. Two research analysts have rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $550.13.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.